Clinical Trial Update: Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

View source ↗

Summary

This document reports the completion of a safety surveillance trial for golimumab using the Ingenix NHI database to monitor safety in rheumatoid arthritis, psor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Janssen Biotech, Inc. | Conditions: Rheumatoid Arthritis, Arthritis, Psoriatic | Status: COMPLETED